| abstract |
The present invention relates to compound of formula (I): n n n n n n n n n n whereinn nR is O—R 3 orn n n n n n n n n n n R 1 and R 2 are identical or different and are each independently H, (C 1 -C 6 )alkyl, —CO—(C 1 -C 21 )alkyl or —CO—(C 11 -C 21 )alkenyl group, provided that at least one of R 1 or R 2 is H or (C 1 -C 6 )alkyl,n nR 3 is a —CO—(C 11 -C 21 )alkyl or —CO—(C 11 -C 21 )alkenyl group,n nor its pharmaceutically acceptable salts, racemates, diastereoisomers, enantiomers, or mixtures thereof,n nfor use in prevention and/or treatment of a disease or disorder linked to an exacerbated vascular, lymphatic or mucosal permeability. |